Companies:
52,899
Total Market Cap:
166634100923335.50
Biodexa Pharmaceuticals Plc
NASDAQ: BDRX
Healthcare
Biotechnology
Global Rank
#51468
Country Rank
#1302
Market Cap
373,036
Price
2.9
Change (%)
15.45%
Volume
11,329
Biodexa Pharmaceuticals Plc's latest marketcap:
373,036
As of 11/02/2026, Biodexa Pharmaceuticals Plc's market capitalization has reached $373,036. According to our data, Biodexa Pharmaceuticals Plc is the 51468th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 373,036 |
| Revenue (ttm) | 104,895 |
| Net Income (ttm) | -5,864,402 |
| Shares Out | 128,633 |
| EPS (ttm) | -102.5 |
| Forward PE | 0.00 |
| Ex-Dividend Date | n/a |
| Earnings Date | 09/11/2026 |
Market Cap Chart
Data Updated: 11/02/2026
Biodexa Pharmaceuticals Plc's yearly market capitalization.
Biodexa Pharmaceuticals Plc has seen its market value drop from $77.6 M to $373,036 since 2015, representing a total decrease of 99.52% and an annual compound decline rate (CAGR) of 38.88%.
| Date | Market Cap($) | Change (%) | Global Rank |
|---|---|---|---|
| 11/02/2026 | $373,036 | -76.83% | 51468 |
| 12/31/2025 | $1.9 M | -19.06% | 42618 |
| 12/31/2024 | $2.35 M | -66.37% | 42899 |
| 12/29/2023 | $6.99 M | 121.92% | 38528 |
| 12/30/2022 | $3.15 M | -96.87% | 38730 |
| 12/31/2021 | $100.8 M | 334.71% | 34548 |
| 12/31/2020 | $23.19 M | 43.76% | 28734 |
| 12/31/2019 | $16.13 M | 246.87% | n/a |
| 12/31/2018 | $4.65 M | -81.49% | n/a |
| 12/29/2017 | $25.12 M | -62.07% | n/a |
Company Profile
Biodexa Pharmaceuticals Plc was founded in 2000 in United Kingdom.
on the Nasdaq Stock Market.
With 11 employees, it focuses on Healthcare and aims to drive innovation in Biotechnology.
Frequently Asked Questions
-
What is Biodexa Pharmaceuticals Plc's (BDRX) current market cap?As of 11/02/2026, Biodexa Pharmaceuticals Plc (including the parent company, if applicable) has an estimated market capitalization of $373,036 USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Biodexa Pharmaceuticals Plc (BDRX) rank globally by market cap?Biodexa Pharmaceuticals Plc global market capitalization ranking is approximately 51468 as of 11/02/2026. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.